Drawing for REFINEDSCIENCE

USPTO serial 98142547

REFINEDSCIENCE

Reviewed by CopyMark Law Group

Reg. 7682112Status 700Registered
Filing date
Status date
Registration date
Feb 4, 2025
Examiner
QUILICI, BRENDAN A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with REFINEDSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole Swartz

Nicole Swartz SETTER ROCHE SMITH & SHELLENBERGER LLP1860 BLAKE STREET, STE. 500DENVER, CO 80202United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Providing independent review of clinical trials for business purposesACTIVEJan 10, 2024
042Compiling data for research purposes in the field of medical science and medical consultancy; Consultancy in the field of artificial intelligence technology; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) services featuring software using artificial intelligence for predicting clinical pharmaceutical trial success and for tracking and predicting biomarker and biosignature identifications in clinical pharmaceutical trials; Software design and development; Technical consulting in the field of artificial intelligence (AI) software customization; Technical support services, namely, remote and on-site infrastructure management services for monitoring, administration and management of public and private cloud computing IT and application systemsACTIVEJan 10, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 14, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 10, 2024DOCKASSIGNED TO EXAMINER—
Dec 6, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 5, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 24, 2024IUAFUSE AMENDMENT FILED—
Sep 24, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2024DOCKASSIGNED TO EXAMINER—
Sep 19, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance